ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast
(Source: Annals of Surgical Oncology)
Source: Annals of Surgical Oncology - September 11, 2023 Category: Cancer & Oncology Source Type: research
ASO Visual Abstract: Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy
(Source: Annals of Surgical Oncology)
Source: Annals of Surgical Oncology - September 11, 2023 Category: Cancer & Oncology Source Type: research
ASO Visual Abstract: Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70? A National Cancer Database (NCDB) Analysis of Sentinel Node Practice Patterns
(Source: Annals of Surgical Oncology)
Source: Annals of Surgical Oncology - September 11, 2023 Category: Cancer & Oncology Source Type: research
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
This study examined associations with risk factors using data from 3075 DCIS cases, 338 LCIS cases, and 1584 controls aged 35-60, recruited from the UK-based GLACIER and ICICLE case-control studies between 2007 and 2012. Analysis showed that breastfeeding in parous women was protective against DCIS and LCIS, which is consistent with research on invasive breast cancer (IBC). Additionally, long-term use of HRT in post-menopausal women increased the risk of DCIS and LCIS, with a stronger association in LCIS, similar to the association with ILC. Contrary to findings with IBC, parity and the number of births were not protective...
Source: Cancer Control - September 9, 2023 Category: Cancer & Oncology Authors: Jasmine Timbres Kelly Kohut Michele Caneppele Maria Troy Marjanka K Schmidt Rebecca Roylance Elinor Sawyer Source Type: research
Management of screening-detected lobular neoplasia in the era of digital breast tomosynthesis: A preliminary study
CONCLUSIONS: The upgrade rate of screening DBT-detected lobular neoplasia is less than 6%. Surveillance rather than surgery can be considered for lobular neoplasia, particularly in patients with ALH and in those with screening-detected calcifications leading to the diagnosis.PMID:37673705 | DOI:10.1016/j.clinimag.2023.109979 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - September 6, 2023 Category: Cancer & Oncology Authors: Yukun Gao Manisha Bahl Source Type: research
Management of screening-detected lobular neoplasia in the era of digital breast tomosynthesis: A preliminary study
CONCLUSIONS: The upgrade rate of screening DBT-detected lobular neoplasia is less than 6%. Surveillance rather than surgery can be considered for lobular neoplasia, particularly in patients with ALH and in those with screening-detected calcifications leading to the diagnosis.PMID:37673705 | DOI:10.1016/j.clinimag.2023.109979 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - September 6, 2023 Category: Cancer & Oncology Authors: Yukun Gao Manisha Bahl Source Type: research
Management of screening-detected lobular neoplasia in the era of digital breast tomosynthesis: A preliminary study
CONCLUSIONS: The upgrade rate of screening DBT-detected lobular neoplasia is less than 6%. Surveillance rather than surgery can be considered for lobular neoplasia, particularly in patients with ALH and in those with screening-detected calcifications leading to the diagnosis.PMID:37673705 | DOI:10.1016/j.clinimag.2023.109979 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - September 6, 2023 Category: Cancer & Oncology Authors: Yukun Gao Manisha Bahl Source Type: research
Management of screening-detected lobular neoplasia in the era of digital breast tomosynthesis: A preliminary study
CONCLUSIONS: The upgrade rate of screening DBT-detected lobular neoplasia is less than 6%. Surveillance rather than surgery can be considered for lobular neoplasia, particularly in patients with ALH and in those with screening-detected calcifications leading to the diagnosis.PMID:37673705 | DOI:10.1016/j.clinimag.2023.109979 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - September 6, 2023 Category: Cancer & Oncology Authors: Yukun Gao Manisha Bahl Source Type: research
Cancers, Vol. 15, Pages 4397: DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
This study examined associations with risk factors using data from 3075 DCIS cases, 338 LCIS cases, and 1584 controls aged 35–60, recruited from the UK-based GLACIER and ICICLE case-control studies between 2007 and 2012. Analysis showed that breastfeeding in parous women was protective against DCIS and LCIS, which is consistent with research on invasive breast cancer (IBC). Additionally, long-term use of HRT in post-menopausal women increased the risk of DCIS and LCIS, with a stronger association in LCIS, similar to the association with ILC. Contrary to findings with IBC, parity and the number of births were ...
Source: Cancers - September 2, 2023 Category: Cancer & Oncology Authors: Jasmine Timbres Kelly Kohut Michele Caneppele Maria Troy Marjanka K. Schmidt Rebecca Roylance Elinor Sawyer Tags: Article Source Type: research
Po121
Invasive lobular carcinoma (ILC) is the second most common breast cancer histology, classically defined by its “single file” appearance and multifocal presentation. Historically this cohort of patients has been considered cautionary for accelerated partial breast irradiation (APBI), given concern for increased risks of recurrence and under-representation on randomized controlled trials. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Hari Menon, Charles R. Wallace, Jessica M. Schuster, Kristin A. Bradley, Bethany M. Anderson Source Type: research
Self-reported barriers to screening breast MRI among women at high risk for breast cancer
CONCLUSIONS: High-risk women reported low uptake of screening breast MRI, indicating a gap in guideline-concordant care. Breast cancer knowledge and screening-supportive social norms are two key areas to target in future interventions. Data were collected during the COVID-19 pandemic and generalizability of results is unclear. Future studies with larger, more heterogeneous samples are needed to replicate these findings.PMID:37640965 | DOI:10.1007/s10549-023-07085-w (Source: Cancer Control)
Source: Cancer Control - August 28, 2023 Category: Cancer & Oncology Authors: Claire C Conley Jennifer D Rodriguez McKenzie McIntyre Naomi C Brownstein Bethany L Niell Suzanne C O'Neill Susan T Vadaparampil Source Type: research
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry
ConclusionLuminal ILC had a poorer prognosis than luminal IDC, contributing to the worse prognosis of ILC than that of IDC in the overall cohort. Different therapeutic approaches from luminal IDC are essential for a better prognosis of luminal ILC. (Source: Breast Cancer Research and Treatment)
Source: Breast Cancer Research and Treatment - August 27, 2023 Category: Cancer & Oncology Source Type: research
Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases
ConclusionILC patients had a higher mastectomy rate, higher surgical margin rate and distant metastasis rate than IDC patients. There is no significant difference in DFS or OS between ILC and IDC patients. Mastectomy was associated with poor outcomes regardless of ILC or IDC. (Source: Breast Cancer Research and Treatment)
Source: Breast Cancer Research and Treatment - August 27, 2023 Category: Cancer & Oncology Source Type: research
ASO Visual Abstract: Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70? A National Cancer Database (NCDB) Analysis of Sentinel Node Practice Patterns
Ann Surg Oncol. 2023 Aug 26. doi: 10.1245/s10434-023-13992-5. Online ahead of print.NO ABSTRACTPMID:37626253 | DOI:10.1245/s10434-023-13992-5 (Source: Ann Oncol)
Source: Ann Oncol - August 25, 2023 Category: Cancer & Oncology Authors: Nicole H Goldhaber Thomas O'Keefe Jessica Kang Sasha Douglas Sarah L Blair Source Type: research
